Holen Sie sich die Stockscreener-App
36.01
3.12%
-1.16
Handel nachbörslich:
36.01
Janux Therapeutics Inc Aktie (JANX) Neueste Nachrichten
Trend Tracker for (JANX) - Stock Traders Daily
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Lester Murray Antman dba SimplyRich - MarketBeat
abrdn plc Acquires New Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average PT from Analysts - MarketBeat
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average Price Target from Brokerages - Defense World
Quarterly Snapshot: Quick and Current Ratios for Janux Therapeutics Inc (JANX) - The Dwinnex
Mid-Cap Biopharma’s Biggest Winners And Losers Of 2024 - insights.citeline.com
Andrew Hollman Meyer Sells 3,334 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - MarketBeat
Janux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%Still a Buy? - MarketBeat
Janux Therapeutics (NASDAQ:JANX) Shares Down 4.2%Here's Why - MarketBeat
Janux Therapeutics Inc (NASDAQ: JANX) Gain Of 80.16% Compared To 52-Week Low; YTD Fall -26.47% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Janux Therapeutics Inc (JANX): Is It Worth A Small Bite At $40.68? - Stocks Register
Janux therapeutics' chief business officer sells shares worth $140,999 - MSN
The Volatility of Janux Therapeutics Inc’s (JANX) Stock: A -9.18% Ratio for the Week - The News Heater
Janux Therapeutics Inc (JANX) is looking forward to a strong quarter - SETE News
A Tale of Resilience: Janux Therapeutics Inc Amid Stock Market Turbulence - The InvestChronicle
Janux therapeutics’ chief business officer sells shares worth $140,999 By Investing.com - Investing.com Nigeria
Janux therapeutics' chief business officer sells shares worth $140,999 By Investing.com - Investing.com South Africa
Insider Sell Alert: Andrew Meyer Sells Shares of Janux Therapeutics Inc (JANX) - GuruFocus.com
Short Interest in Janux Therapeutics, Inc. (NASDAQ:JANX) Rises By 19.8% - MarketBeat
Janux Therapeutics Inc (JANX) stock on the rise: An overview - US Post News
Market Recap: Janux Therapeutics Inc (JANX)’s Negative Momentum, Closing at 42.07 - The Dwinnex
Monitoring Janux Therapeutics Inc (JANX) after recent insider movements - Knox Daily
Nisa Investment Advisors LLC Cuts Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat
Nisa Investment Advisors LLC Trims Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Core Scientific's chief legal officer sells $410,473 in stock - MSN
Thomas Barnes named CEO of Averna - BioCentury
Advanced Renal Cell Carcinoma Pipeline 2024: Comprehensive - openPR
JPMorgan Chase & Co. Decreases Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
How to Take Advantage of moves in (JANX) - Stock Traders Daily
Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer - BioSpace
Janux Therapeutics, Inc. Promotes Zachariah McIver to Chief Medical Officer -January 24, 2025 at 04:01 pm EST - Marketscreener.com
Janux Therapeutics Names McIver as Chief Medical Officer - MarketWatch
Janux Therapeutics (NASDAQ:JANX) Trading 6.2% HigherHere's What Happened - MarketBeat
Cantor Fitzgerald Forecasts JANX FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts JANX FY2025 Earnings - MarketBeat
Janux Therapeutics surges amid report of takeover interest - MSN
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):